Alexandra Infanzon Santiago
Physician Assistant · Hickory, NCNPI 1033749411
Payments from drug & device makers
Across 762 payments — averaging $20.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$2K
- Johnson & Johnson$2K
- Alkermes, Inc.$2K
- Neurocrine Biosciences, Inc.$1K
- AbbVie$1K
- Otsuka America Pharmaceutical, Inc.$919
- plus $7K from 24 others
What the payments were for
- Food & beverage$15,81599%
- Education$931%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 103 | $2,497 |
| Johnson & Johnson | 49 | $1,711 |
| Alkermes, Inc. | 58 | $1,546 |
| Neurocrine Biosciences, Inc. | 58 | $1,473 |
| AbbVie | 67 | $1,123 |
| Otsuka America Pharmaceutical, Inc. | 53 | $919 |
| Teva Pharmaceuticals USA, Inc. | 40 | $854 |
| Corium, LLC | 37 | $675 |
| Axsome Therapeutics, Inc. | 45 | $647 |
| Takeda Pharmaceuticals U.S.A., Inc. | 43 | $633 |
| Bausch Health US, LLC | 29 | $560 |
| Lundbeck LLC | 35 | $558 |
| Vanda Pharmaceuticals Inc. | 18 | $413 |
| E.r. Squibb & Sons, L.L.C. | 21 | $387 |
| Idorsia Pharmaceuticals US Inc | 16 | $373 |
| Sunovion Pharmaceuticals Inc. | 23 | $349 |
| Supernus Pharmaceuticals, Inc. | 17 | $285 |
| Indivior Inc. | 9 | $197 |
| Acadia Pharmaceuticals Inc | 10 | $177 |
| Noven Therapeutics, LLC | 5 | $88 |
| Novo Nordisk | 5 | $75 |
| Neos Therapeutics, LP | 4 | $72 |
| Tris Pharma Inc | 5 | $70 |
| Luye Pharma (USA) Ltd. | 3 | $70 |
| Eisai Inc. | 3 | $49 |
| Almatica Pharma LLC | 2 | $26 |
| Alfasigma USA, Inc. | 1 | $25 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $23 |
| Lilly USA, LLC | 1 | $20 |
| Ironshore Pharmaceuticals Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$15,908 in reported general payments places this provider in the 95th percentile of 7,441 physician assistant providers in North Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| IngrezzaValbenazine Tosylate | 33 | $265,249 |
| CaplytaLumateperone Tosylate | 21 | $40,073 |
| AristadaAripiprazole Lauroxil | 11 | $39,192 |
| RexultiBrexpiprazole | 24 | $37,659 |
| LybalviOlanzapine/Samidorphan Malate | 21 | $34,457 |
| OzempicSemaglutide | 27 | $31,148 |
| SpravatoEsketamine Hcl | 26 | $28,221 |
| Clozapine | 56 | $3,622 |
| Bupropion XlBupropion Hcl | 75 | $2,761 |
| Vilazodone Hcl | 11 | $1,623 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 21 | $1,165 |
| Gabapentin | 53 | $929 |
| Olanzapine | 17 | $835 |
| Lamotrigine | 51 | $828 |
| Lurasidone Hcl | 13 | $599 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Neurocrine Biosciences, Inc.Ingrezza | $1,473 | $265,24933 claims |
| Alkermes, Inc.Aristada, Lybalvi | $1,546 | $73,65032 claims |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta | $2,497 | $40,07321 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $919 | $37,65924 claims |
| Novo NordiskOzempic | $75 | $31,14827 claims |
| Johnson & JohnsonSpravato | $1,711 | $28,22126 claims |
| Lilly USA, LLCOlanzapine | $20 | $83517 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 7,441 physician assistant providers in North Carolina.
Other physician assistant in Hickory
- Sarah PadgettHickory$29K
- Jo HughesGreensboro$814K
- Rachel HolzhauerCharlotte$739K
- Amber BlairCharlotte$551K
- Benjamin EpsteinDavidson$447K
- Rebecca KrausDavidson$425K
- Brooke JonesGoldsboro$259K
- Philip ReasbeckWilson$180K
- Katherine SchultzHuntersville$164K
- Kristin CabedaCharlotte$135K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.